Form 4 for WLTH WEALTHFRONT CORP
Accepted 2025-12-15 00:00:00 ET · period of report 2025-07-14 · accession 0002082564-25-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-15 | 2025-12-11 | WLTH | Fortunato David | CEO, Pres, Dir | M - OptEx | $0.3267 | +3.63M | 2.25M | New | +$1.19M |
| D | 2025-12-15 | 2025-12-11 | WLTH | Fortunato David | CEO, Pres, Dir | S - Sale+OE | $14.00 | -765.2K | 1.48M | -34% | -$10.71M |
| DMI | 2025-12-15 | 2025-12-11 | WLTH | Fortunato David | CEO, Pres, Dir | M - OptEx | $0.7111 | +248.9K | 248.9K | New | +$177.0K |
| DI | 2025-12-15 | 2025-12-11 | WLTH | Fortunato David | CEO, Pres, Dir | S - Sale+OE | $14.00 | -95.4K | 153.5K | -38% | -$1.34M |
| D | 2025-12-15 | 2025-12-11 | WLTH | Fortunato David | CEO, Pres, Dir | F - Tax | $14.00 | -1.53M | 1.62M | -49% | -$21.39M |
| D | 2025-12-15 | 2025-07-14 | WLTH | Fortunato David | CEO, Pres, Dir | A - Grant | $0.00 | +141.6K | 141.6K | New | $0 |
| DMI | 2025-12-15 | 2025-12-11 | WLTH | Fortunato David | CEO, Pres, Dir | M - OptEx | $0.00 | -248.9K | 0 | -100% | $0 |
| DM | 2025-12-15 | 2025-12-11 | WLTH | Fortunato David | CEO, Pres, Dir | M - OptEx | $0.00 | -3.63M | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-11 | M | A | 242,000 | $1.67 | 2,083,421 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-11 | M | A | 220,000 | $2.45 | 1,841,421 | D | — | — | |
| 3 | Common | Common Stock | 2025-12-11 | S | D | 765,154 | $14.00 | 1,481,051 | D | — | — | |
| 4 | Common | Common Stock | 2025-12-11 | M | A | 143,000 | $0.00 | 143,000 | I By Spouse | — | — | (F3) The reported securities are directly held by the reporting person's spouse. |
| 5 | Common | Common Stock | 2025-12-11 | M | A | 35,919 | $0.00 | 178,919 | I By Spouse | — | — | (F3) The reported securities are directly held by the reporting person's spouse. |
| 6 | Common | Common Stock | 2025-12-11 | M | A | 45,000 | $2.45 | 223,919 | I By Spouse | — | — | (F3) The reported securities are directly held by the reporting person's spouse. |
| 7 | Common | Common Stock | 2025-12-11 | M | A | 25,000 | $2.67 | 248,919 | I By Spouse | — | — | (F3) The reported securities are directly held by the reporting person's spouse. |
| 8 | Common | Common Stock | 2025-12-11 | S | D | 95,416 | $14.00 | 153,503 | I By Spouse | — | — | (F3) The reported securities are directly held by the reporting person's spouse. |
| 9 | Common | Common Stock | 2025-12-11 | M | A | 95,880 | $0.00 | 236,250 | D | — | — | |
| 10 | Common | Common Stock | 2025-12-11 | M | A | 383,519 | $0.00 | 619,769 | D | — | — | |
| 11 | Common | Common Stock | 2025-12-11 | M | A | 599,200 | $0.00 | 1,218,969 | D | — | — | |
| 12 | Common | Common Stock | 2025-12-11 | M | A | 764,625 | $0.00 | 1,983,594 | D | — | — | |
| 13 | Common | Common Stock | 2025-12-11 | M | A | 253,521 | $0.00 | 2,237,115 | D | — | — | |
| 14 | Common | Common Stock | 2025-12-11 | M | A | 475,087 | $0.00 | 2,712,202 | D | — | — | |
| 15 | Common | Common Stock | 2025-12-11 | M | A | 176,560 | $0.00 | 2,888,762 | D | — | — | |
| 16 | Common | Common Stock | 2025-12-11 | M | A | 119,062 | $0.00 | 3,007,824 | D | — | — | |
| 17 | Common | Common Stock | 2025-12-11 | M | A | 141,600 | $0.00 | 3,149,424 | D | — | — | |
| 18 | Common | Common Stock | 2025-12-11 | F | D | 1,528,003 | $14.00 | 1,621,421 | D | — | — | |
| 19 | Common | Common Stock | 2025-12-11 | M | A | 162,784 | $1.50 | 2,246,205 | D | — | — | |
| 20 | Derivative | Restricted Stock Units | 2025-07-14 | A | A | 141,600 | $0.00 | 141,600 | D | — · — to — | 141,600 Common Stock | (F5) The transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the IPO, and the transaction is reported herein pursuant to Rule 16a-2(a). (F6) This restricted stock unit award represents an equity security previously reported on the reporting person's Form 3, which was acquired through an exempt transaction with the Issuer. (F4) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. (F7) The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO and a service-based vesting requirement which was deemed satisfied as of the grant date, July 14, 2025. The entire award was settled for shares of the Issuer's Common Stock in connection with the IPO. (F8) These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. |
| 21 | Derivative | Stock Option (Right to Buy) | 2025-12-11 | M | D | 25,000 | $0.00 | 0 | I By Spouse | $2.67 · — to 2026-12-01 | 25,000 Common Stock | (F3) The reported securities are directly held by the reporting person's spouse. (F23) The option is fully vested. Pursuant to the terms of the reporting person's spouse's award agreement with the Issuer, the award became fully vested on October 24, 2020. |
| 22 | Derivative | Restricted Stock Units | 2025-12-11 | M | D | 383,519 | $0.00 | 0 | D | — · — to — | 383,519 Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. (F10) The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO and a service-based vesting requirement which was deemed satisfied as of the grant date, November 22, 2022. The entire award was settled for shares of the Issuer's Common Stock in connection with the IPO. (F8) These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. |
| 23 | Derivative | Restricted Stock Units | 2025-12-11 | M | D | 599,200 | $0.00 | 0 | D | — · — to — | 599,200 Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. (F11) The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO and a service-based vesting requirement which was deemed satisfied as of the grant date, January 25, 2023. The entire award was settled for shares of the Issuer's Common Stock in connection with the IPO. (F8) These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. |
| 24 | Derivative | Restricted Stock Units | 2025-12-11 | M | D | 764,625 | $0.00 | 458,775 | D | — · — to — | 764,625 Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. (F12) The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO, as well as a service-based vesting schedule. The award vested or vests as to 1/16 of the total award quarterly on the fifteenth calendar day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche time-vested on June 15, 2023. Time-vested portions of the award were settled for shares of the Issuer's Common Stock in connection with the IPO. (F8) These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. |
| 25 | Derivative | Restricted Stock Units | 2025-12-11 | M | D | 253,521 | $0.00 | 0 | D | — · — to — | 253,521 Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. (F13) The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO and a service-based vesting requirement which was deemed satisfied as of the grant date, August 4, 2023. The entire award was settled for shares of the Issuer's Common Stock in connection with the IPO. (F8) These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. |
| 26 | Derivative | Restricted Stock Units | 2025-12-11 | M | D | 475,087 | $0.00 | 791,813 | D | — · — to — | 475,087 Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. (F14) The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO, as well as a service-based vesting schedule. The award vested as to 1/16 of the total award quarterly on the fifteenth calendar day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche time-vested on June 15, 2024. Time-vested portions of the award were settled for shares of the Issuer's Common Stock in connection with the IPO. (F8) These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. |
| 27 | Derivative | Restricted Stock Units | 2025-12-11 | M | D | 176,560 | $0.00 | 0 | D | — · — to — | 176,560 Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. (F15) The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO and a service-based vesting requirement which was deemed satisfied as of the grant date, October 21, 2024. The entire award was settled for shares of the Issuer's Common Stock in connection with the IPO. (F8) These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. |
| 28 | Derivative | Restricted Stock Units | 2025-12-11 | M | D | 119,062 | $0.00 | 833,438 | D | — · — to — | 119,062 Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. (F16) The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO, as well as a service-based vesting schedule. The award vested as to 1/16 of the total award quarterly on the fifteenth calendar day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche time-vested on June 15, 2025. Time-vested portions of the award were settled for shares of the Issuer's Common Stock in connection with the IPO. (F8) These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. |
| 29 | Derivative | Restricted Stock Units | 2025-12-11 | M | D | 141,600 | $0.00 | 0 | D | — · — to — | 141,600 Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. (F17) The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO and a service-based vesting requirement which was deemed satisfied as of the grant date, July 14, 2025. The entire award was settled for shares of the Issuer's Common Stock in connection with the IPO. (F8) These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. |
| 30 | Derivative | Stock Option (Right to Buy) | 2025-12-11 | M | D | 220,000 | $0.00 | 0 | D | $2.45 · — to 2026-05-26 | 220,000 Common Stock | (F18) The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on May 23, 2020. |
| 31 | Derivative | Stock Option (Right to Buy) | 2025-12-11 | M | D | 242,000 | $0.00 | 0 | D | $1.67 · — to 2027-10-17 | 242,000 Common Stock | (F19) The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on May 17, 2021. |
| 32 | Derivative | Stock Option (Right to Buy) | 2025-12-11 | M | D | 162,784 | $0.00 | 23,658 | D | $1.50 · — to 2028-02-13 | 162,784 Common Stock | (F20) The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on December 27, 2021. |
| 33 | Derivative | Restricted Stock Units | 2025-12-11 | M | D | 143,000 | $0.00 | 0 | I By Spouse | — · — to — | 143,000 Common Stock | (F3) The reported securities are directly held by the reporting person's spouse. (F4) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. (F10) The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO and a service-based vesting requirement which was deemed satisfied as of the grant date, November 22, 2022. The entire award was settled for shares of the Issuer's Common Stock in connection with the IPO. (F8) These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. |
| 34 | Derivative | Restricted Stock Units | 2025-12-11 | M | D | 35,919 | $0.00 | 0 | I By Spouse | — · — to — | 35,919 Common Stock | (F3) The reported securities are directly held by the reporting person's spouse. (F4) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. (F21) The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO, as well as a service-based vesting schedule. The award vested as to 1/8 of the total award quarterly on the fifteenth calendar day of March, June, September, and December, subject to the reporting person's spouse's continued service to the Issuer on each vesting date, with the first tranche time-vested on March 15, 2023. Although the award ceased vesting following the reporting person's spouse's separation from service to the issuer, the entire outstanding portion of the award was settled for shares of the Issuer's Common Stock in connection with the IPO. (F8) These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. |
| 35 | Derivative | Stock Option (Right to Buy) | 2025-12-11 | M | D | 45,000 | $0.00 | 0 | I By Spouse | $2.45 · — to 2026-09-28 | 45,000 Common Stock | (F3) The reported securities are directly held by the reporting person's spouse. (F22) The option is fully vested. Pursuant to the terms of the reporting person's spouse's award agreement with the Issuer, the award became fully vested on August 15, 2020. |
| 36 | Derivative | Restricted Stock Units | 2025-12-11 | M | D | 95,880 | $0.00 | 0 | D | — · — to — | 95,880 Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. (F9) The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO, as well as a service-based vesting schedule. The award vested as to 1/8 of the total award quarterly on the fifteenth calendar day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche time-vested on March 15, 2023. The award was fully time-vested as of December 15, 2024, and the entire award was settled for shares of the Issuer's Common Stock in connection with the IPO. (F8) These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. |